These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23459088)

  • 1. Concepts and practices used to develop functional PLGA-based nanoparticulate systems.
    Sah H; Thoma LA; Desu HR; Sah E; Wood GC
    Int J Nanomedicine; 2013; 8():747-65. PubMed ID: 23459088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers.
    Chen W; Hu S
    Int J Nanomedicine; 2011; 6():1535-41. PubMed ID: 21845043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
    Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
    Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.
    Colzani B; Speranza G; Dorati R; Conti B; Modena T; Bruni G; Zagato E; Vermeulen L; Dakwar GR; Braeckmans K; Genta I
    Int J Pharm; 2016 Sep; 511(2):1112-23. PubMed ID: 27511710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni.
    Lima TC; Lucarini R; Luz PP; de Faria EH; Marçal L; Magalhães LG; Badoco FR; Esperandim VR; Molina EF; Laurentz RS; Lima RG; Cunha WR; Bastos JK; Silva MLA
    Pharm Biol; 2017 Dec; 55(1):2270-2276. PubMed ID: 29172838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
    J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
    Xin L; Zhang HT; Yang WF; Li YF; Liu C
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29229675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.
    Joung YK; Son S; Jang JY; Kwon MH; Park KD
    Pharm Res; 2012 Apr; 29(4):932-42. PubMed ID: 22139535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents.
    Dinarvand R; Sepehri N; Manoochehri S; Rouhani H; Atyabi F
    Int J Nanomedicine; 2011; 6():877-95. PubMed ID: 21720501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
    Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
    J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
    Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
    Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.
    Wang Z; Chui WK; Ho PC
    Pharm Res; 2009 May; 26(5):1162-71. PubMed ID: 19191012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.